Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty

Catheterization and Cardiovascular Diagnosis

Volumn 37, Issue 4, 1996, Pages 382-391

  Gurbel, Paul A ^b   Navetta, Frank I ^b   Bates, Eric R ^b   Muller, David W ^b   Tenaglia, Alan N ^b   Miller, Michael J ^b   Muhlstein, Brent ^b   Hermiller, James B ^b   Davidson, Charles J ^b   Aguirre, Frank V ^b   Beauman, Glenn J ^b   Berdan, Lisa G ^b   Leimberger, Jeffrey D ^b   Bovill, Edwin G ^b   Christenson, Robert H ^b   Ohman, E Magnus ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

anticoagulation; PTCA; thrombolysis; thrombus

Indexed keywords

ALTEPLASE; FIBRINOGEN; HEPARIN; THROMBIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY THROMBOSIS; FEMALE; FIBRINOGEN METABOLISM; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; CREATINE KINASE; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; FEMALE; FIBRINOLYSIS; HEPARIN; HUMANS; INJECTIONS, INTRALESIONAL; ISOENZYMES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 9044252717     PISSN: 00986569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0304(199604)37:4<382::AID-CCD8>3.0.CO;2-7     Document Type: Article

References (36)

1. Sugrue DD, Holmes DR Jr., Smith HC, Reeder GS, Lane GE, Vlietstra RE, Bresnahan JF, Hammes LN, Piehler JM: Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: Improving results. Br Heart J 56:62-66, 1986.
2. Ellis SG, Roubin GS, King SB III, Douglas JS, Weintraub WS, Thomas RG, Cox WR: Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 77:372-379, 1988.
3. Detre KM, Holmes DR Jr., Holubkov R, Cowley MJ, Bourassa MG, Faxon DP, Dorros GR, Bentivoglio LG, Kent KM, Myler RK: Incidence and consequences of periprocedural occlusion. Circulation 82:739-750, 1990.
4. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ: Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol 19:926-935, 1992.
5. Tenaglia AN, Fortin DF, Califf RM, Frid DJ, Nelson CL, Gardner L, Miller M, Navetta FI, Smith JE, Tcheng JE, Stack RS: Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. J Am Coll Cardiol 24:1004-1011, 1994.
6. Ambrose JA, Torre SR, Sharma SK, Israel DH, Monsen CE, Weiss M, Untereker W, Grunwald A, Moses J, Marshall J, Bunnell P, Sobolski J: Adjunctive thrombolytic therapy for angioplasty in ischemic rest angina: Results of a double-blind randomized pilot study. J Am Coll Cardiol 20:1197-1204, 1992.
7. Vetrovec GW, Leinbach RC, Gold HK, Cowley MJ: Intracoronary thrombolysis in syndromes of unstable ischemia: Angiographic and clinical results. Am Heart J 104:946-952, 1982.
8. Mandelkorn JB, Wolf NM, Singh S, Shechter JA, Kersh RI, Rodgers DM, Workman MB, Bentivoglio LG, LaPorte SM, Meister SG: Intracoronary thrombus in nontransmural myocardial infarction and in unstable angina pectoris. Am J Cardiol 52:1-6, 1983.
9. Ambrose JA, Hjemdahl-Monsen C, Borrico S, Sherman W, Cohen M, Gorlin R, Fuster V: Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction. J Am Coll Cardiol 9:1156-1165, 1987.
10. Gotoh K, Minamino T, Katoh O, Hamano Y, Fukui S, Hori M, Kusuoka H, Mishima M, Inoue M, Kamada T: The role of intracoronary thrombus in unstable angina: Angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation 77:526-534, 1988.
11. Goudreau E, DiSciascio G, Vetrovec GW, Chami Y, Kohli R, Warner M, Sabri N, Cowley MJ: Intracoronary urokinase as an adjunct to percutaneous transluminal coronary angioplasty in patients with complex coronary narrowings or angioplasty-induced complications. Am J Cardiol 69:57-62, 1992.
12. DiSciascio G, Kohli RS, Goudreau E, Sabri N, Vetrovec GW: Intracoronary recombinant tissue-type plasminogen activator in unstable angina: A pilot angiographic study. Am Heart J 122:1-6, 1991.
13. Ambrose JA, Almeida OD, Sharma SK, Torre SR, Marmur JD, Israel DH, Ratner DE, Weiss MB, Hjemdahl-Monsen CE, Myler RK, Moses J, Unterecker WJ, Grunwald AM, Garrett JS, Cowley MJ, Anwar A, Sobolski J, for the TAUSA Investigators: Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina: Results of the TAUSA trial. Circulation 90:69-77, 1994.
14. Chapekis AT, George BS, Candela RJ: Rapid thrombus dissolution by continuous infusion of urokinase through an intracoronary perfusion wire prior to and following PTCA: Results in native coronaries and patent saphenous vein grafts. Cathet Cardiovasc Diagn 23:89-92, 1991.
15. Gurbel PA, Davidson CJ, Ohman EM, Smith JE, Stack RS: Selective infusion of thrombolytic therapy in the acute myocardial infarct-related coronary artery as an alternative to rescue percutaneous transluminal coronary angioplasty. Am J Cardiol 66: 1021-1023, 1990.
16. Owen J, Friedman KD, Grossman BA, Wilkins C, Berke AD, Powers ER: Thrombolytic therapy with tissue plasminogen activator or streptokinase induces transient thrombin activity. Blood 72:616-620, 1988.
17. Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Rafflenbeul W, Daniel WG, Hecker H, Lichtlen PR: Increased thrombin levels during thrombolytic therapy in acute myocardial infarction: Relevance for the success of therapy. Circulation 83:937-944, 1991.
18. Rapold HJ, Kuemmerli H, Weiss M, Baur H, Haeberli A: Monitoring of fibrin generation during thrombolytic therapy of acute myocardial infarction with recombinant tissue-type plasminogen activator. Circ Res 79:980-989, 1989.
19. Eisenberg PR, Sherman L, Rich M, Schwartz D, Schechtman K, Geltman EM, Sobel BE, Jaffe AS: Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis. J Am Coll Cardiol 7:1255-1262, 1986.
20. Cercek B, Lew AS, Hod H, Yano J, Reddy NK, Ganz W: Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin. Circulation 74:583-587, 1986.
21. The TIMI IIIA Investigators: Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischémie cardiac pain at rest. Circulation 87:38-52, 1993.
22. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E: Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76:142-154, 1987.
23. Trask N, Califf RM, Conley MJ, Kong Y, Peter R, Lee KL, Hackel DB, Wagner GS: Accuracy and interobserver variability of coronary cineangiography: A comparison with postmortem evaluation. J Am Coll Cardiol 3:1145-1154, 1984.
24. Mancini GB, Simon SB, McGillem MJ, LeFree MT, Friedman HZ, Vogel RA: Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographie method. Circulation 75:452-460, 1987.
25. Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, Collen D, Feit F, Gore JM, Hillis LD, Lambrew CT, Leiboff R, Mann KG, Markis JE, Pratt CM, Sharkey SW, Sopko G, Tracy RP, Chesebro JH: Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. Ann Intern Med 115:256-265, 1991.
26. Lawler CM, Bovill EG, Stump DC, Collen DJ, Mann KG, Tracy RP: Fibrin fragment D-dimer and fibrinogen β peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction. Blood 76:1341-1348, 1990.
27. Granger CB, Miller JM, Bovill EG, Gruber A, Tracy RP, Krucoff MW, Green C Berrios E, Harrington RA, Ohman EM: Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes. Circulation 91:1929-1935, 1995.
28. Gold HK, Torres FW, Garabedian HD, Werner W, Jang I-K, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB, Bovill EG, Stump DC, Collen D: Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pec toris. J Am Coll Cardiol 21:1039-1047, 1993.
29. Ruocco NA Jr, Currier JW, Jacobs AK, Ryan TJ, Faxon DP: Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty. Am J Cardiol 68: 1609-1613, 1991.
30. Krupski WC, Feldman RK, Rapp JH: Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: Preliminary report. J Vasc Surg 10:491-500, 1989.
31. Mitchel JF, Azrin MA, Fram DB, Hong MK, Wong SC, Barry JJ, Bow LM, Curley TM, Kiernan FJ, Waters DD, Leon MB, McKay RG: Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons. Circulation 90:1979-1988, 1994.
32. Goldman B, Blanke H, Wolinsky H: Influence of pressure on permeability of normal and diseased muscular arteries to horse-radish peroxidase. A new catheter approach. Atherosclerosis 65: 212-225, 1987.
33. Sobel BE: Coronary thrombolysis and the new biology. J Am Coll Cardiol 14:850-860, 1989.
34. Hillegass WB, Ohman EM, O'Hanesian MA, Harrington RA, Faxon DP, Fortin DF, Ellis SG, Stack RS, Holmes DR Jr, Califf RM: The effect of preprocedural intracoronary thrombus on patient outcome after percutaneous coronary intervention (abst). J Am Coll Cardiol 25:94A, 1995.
35. Cumberland DC, Gunn J, Tsikaderis D, Arafa S, Ahsan A: Initial clinical experience of local drug delivery via a porous balloon during percutaneous coronary angioplasty (abst). J Am Coll Cardiol 23:186A, 1994.
36. Mabin TA, Holmes DR Jr, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA: Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 5:198-202, 1985.